Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

This perioperative approach with Imfinzi underscores our commitment to moving into earlier stages of cancer where novel ...

Medicare will cover chemotherapy for treating cancer. Because doctors administer fluorouracil intravenously (via the veins), coverage falls under Part A or B. Part A covers it during a hospital ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the MATTERHORN Phase 3 trial evaluating Imfinzi (durvalumab) as ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The Phase III MATTERHORN trial demonstrated that Imfinzi (durvalumab) plus FLOT chemotherapy significantly improved ...

A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Leukopenia, weight loss and oral ...

A new research paper was published in , Volume 16, on February 18, 2025, titled "Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters' model: A regenerative approach using ...

AstraZeneca (AZ) has shared positive results from a late-stage trial of its Imfinzi (durvalumab)-based perioperative regimen ...

Researchers from the University of Auckland and Auckland City Hospital in New Zealand have begun a clinical trial aiming to improve the safety of the chemotherapy drug 5-fluorouracil. The trial is ...

The control arm used 5-FU with radiation therapy with five cycles of 5-fluorouracil with radiation during cycles two to four followed ... followed by surgery and then six to eight cycles adjuvantly ...